SZTURZ, Petr. Very rare diseases in oncology. Medical oncology. Totowa: HUMANA PRESS INC, 2014, vol. 31, No 5, p. 947-948. ISSN 1357-0560. Available from: https://dx.doi.org/10.1007/s12032-014-0947-y.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Very rare diseases in oncology
Authors SZTURZ, Petr (203 Czech Republic, guarantor, belonging to the institution).
Edition Medical oncology, Totowa, HUMANA PRESS INC, 2014, 1357-0560.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.634
RIV identification code RIV/00216224:14110/14:00075887
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s12032-014-0947-y
UT WoS 000339002800023
Keywords in English oncology diseases
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 17/9/2014 15:50.
Abstract
Chen et al. [1] presented an important study on potential molecular prognostic predictors of recurrence in sacral chordoma. I wish to draw the readers’ attention to epidemiological and related socioeconomic and ethical issues of such a rare diagnosis. Various definitions for sporadic diseases have been proposed based on different cutoff incidence or prevalence rates. Some of these definitions delineate a substantial portion of the overall population disease burden. The apparent complexity of the group of rare diseases implies further explorations including the most uncommon entities.
Links
MUNI/A/0723/2012, interní kód MUName: Nové klinické a diagnostické přístupy u hematogických malignit (Acronym: NoKliDiPřiHeMa)
Investor: Masaryk University, Category A
PrintDisplayed: 27/5/2024 11:27